Beste JCO podcaster (2025)

1
Park the Parking: Patient and Caregiver Perspectives on Transportation Barriers in Cancer 31:09

5d ago31:09

31:09

Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care are incredibly common despite what appears to be relatively straightforward solutions. Dr. Chino welcomes two patient-centered health policy experts …

1
JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC 6:54

18d ago6:54

6:54

JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Thomas Stinchcombe discuss the ASCO 2025 Simultaneous Publication paper "Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small-Cell Lung Cancer." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Ece Cali: Hello, and welcome to our 2025 ASCO …

1
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC 8:42

21d ago8:42

8:42

JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2025 Simultaneous Publication paper "A Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab vs. Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma (cSCC)." Transcript The guest on this podcast episode has no disclosures…

1
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer 6:52

21d ago6:52

6:52

JCO Editorial Fellow Dr. Peter Li and JCO Associate Editor Dr. Andrew Ko discuss the ASCO 25 Simultaneous Publication paper "Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III Randomized LEAP-015 Study." Transcript The guest on this podcast episode has no disclosu…

1
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma 6:24

21d ago6:24

6:24

JCO Editorial Fellow Peter Li and JCO Associate Editor Eileen O'Reilly discuss the ASCO 25 Simultaneous Publication paper "Tumor-Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal, Phase 3 PANOVA-3 Study." Transcript The guest on this podcast episode has no disclosures…

1
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare 8:17

21d ago8:17

8:17

JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Lauren Shih: Hello, and welcome to our 2025 ASC…

1
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome 15:50

23d ago15:50

15:50

In this JCO Article Insights episode, host Michael Hughes summarizes "Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma" by Kaiser et al, published February 18, 2025, followed by an interview with JCO Associate Editor Suzanne Lentzsch. Transcript Michael Hughes: Welcome to t…

1
Pregnancy and Breast Cancer 25:53

1M ago25:53

25:53

Dr. Chino talks with Dr. Erin Roesch and patient advocate Julia Maues about pregnancy associated cancer with a focus on breast cancer, the most common cancer diagnosed during pregnancy. This discussion is based off an JCO OP review article published in late 2024 called “Multidisciplinary Management of Pregnancy-Associated Breast Cancer.” Transcript…

1
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases 23:59

1M ago23:59

23:59

Host Dr. Davide Soldato and guest Dr. Harriet Kluger discuss the JCO article "Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato Hello and welcome to JCO After Hours, the podcast where we sit down wit…

1
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer 6:47

2M ago6:47

6:47

In this JCO Article Insights episode, host Joseph Mathew summaries Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial, by Palmer, et al published December 5, 2024. Transcript Joseph Mathew: Hello and welcome to the Journal of Clinical Oncology Article Insights. I'm your host, Joseph Mathew, and today we …

1
Treatment De-escalation for Favorable Risk Breast Cancer 29:30

2M ago29:30

29:30

Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, shared decision making, and improved quality of life. This discussion will be based off a JCO OP editorial published in late 2024 called “Contextual Fra…

1
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment 26:50

2M ago26:50

26:50

Host Dr. Davide Soldato and guests Dr. Jessica Burris discuss the article "Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons Accredited Cancer Programs" and how persistent smoking following cancer diagnosis causes adverse outcomes while smoking cessation can improve su…

1
JCO Article Insights: Smoking Assessment 8:35

3M ago8:35

8:35

In this JCO Article Insights episode, Lauren Shih summaries "Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs" by Jessica L. Burris, et al published November 19, 2024. Come back for the next episode where JCO After Hours host, Dr. Davide Sol…

1
Prior Authorization: How Did We Get Here and Where Are We Going? 32:05

3M ago32:05

32:05

Dr. Chino discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. TRANSCRIPT Dr. Fumiko Chino: Hello and welcome to Put Into Practice, the podcast for the JCO Oncology Practice. I'm Dr. Fumiko…

1
Botensilimab Plus Balstilimab in Advanced Sarcomas 21:00

3M ago21:00

21:00

Dr. Shannon Westin and her guest, Dr. Breelyn Wilky, discuss the JCO article, "“Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas." TRANSCRIPT Shannon Westin: Hello, everyone, and welcome to another episode of JCO After H…

1
JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer 8:47

4M ago8:47

8:47

In this JCO Article Insights episode, Peter Li summarizes “Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years,” by Dr. Jianwei Zhang et al. published on Dece…

1
Optimizing the Electronic Health Record for Patient-Centered Cancer Care 38:55

4M ago38:55

38:55

Dr. Fumiko Chino talks with Dr. Aditi Singh and patient advocate Liz Salmi about how this essential tool for documentation could be optimized to be more patient-centered. This discussion will be based off the JCO OP article published in late 2024, “Re-Envisioning the Electronic Health Records to Optimize Patient-Centered Cancer Care, Quality, Surve…

1
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer 12:12

4M ago12:12

12:12

Host Dr. Shannon Westin and guests Dr. Bill Aronson discuss the article "High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial" and how Omega-6 are predominant in the American diet while the study significantly lowered the intake of Omega- 6 fats. TRANSCRIPT Dr. Sha…

1
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC 10:21

5M ago10:21

10:21

In this JCO Article Insights episode, Ece Cali summarizes findings from the JCO article, "Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study." TRANSCRIPT Ece Cali: Hello and welcome to the JCO Article Insights. I'm your host Ece …

1
Debt or Dying: The JCO OP Financial Toxicity Special Issue 30:51

5M ago30:51

30:51

Host Dr. Fumiko Chino sits down with co-editor and health outcomes researcher Dr. Ryan Nipp, and contributing author Dr. Kelly Shanahan who is living with metastatic breast cancer to have a candid conversation about financial toxicity, the lived experience for patients, and what we can do to move the needle on affordability in cancer care. TRANSCRI…

1
Air Pollution and Breast Cancer Incidence 25:43

5M ago25:43

25:43

Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article "Air Pollution and Breast Cancer Incidence in the Multiethnic Cohort Study" and the editorial "Growing Evidence for the Role of Air Pollution in Breast Cancer Development" TRANSCRIPT The guests on this podcast episode have no disclosures to declare. Dr. Davide…

1
JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing 9:01

6M ago9:01

9:01

In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on "Navigating Treatment Pathways in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies" by Bhardwarj, et al and "US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant f…

1
Overcoming Barriers to Make Patient-Partnered Research a Reality 34:38

6M ago34:38

34:38

Host Dr. Davide Soldato and guests Dr. Suzanne George and Liz Salmi discuss their JCO article "Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality" TRANSCRIPT TO COME Dr. Davide Soldato: Hello and welcome to JCO’s After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal …

1
JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma 9:42

7M ago9:42

9:42

In this JCO Article Insights episode, Rohit Singh provides a summary on "First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data", by Long et al, published in the November issue of the Journal of Clinical Oncology. The article prov…

1
Quality of Treatment Selection 25:05

7M ago25:05

25:05

Host Dr. Davide Soldato and Dr. Aaron Mitchell discuss the JCO article "Quality of Treatment Selection for Medicare Beneficiaries With Cancer" TRANSCRIPT Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host,…

1
JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy 9:52

8M ago9:52

9:52

In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors" by Schaffer et al published in the Journal of Clinical Oncology July 17th, 2024. TRANSCRIPT Alexandra Rojek:…

1
Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer 16:40

8M ago16:40

16:40

Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article “Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors” recently published in the JCO and presented at the 2024 International Gynecologic Cancer Society. …

1
Wayne Shorter A New Perspective 31:38

8M ago31:38

31:38

The life of Visionary Composer , Musician , Saxophonist and founder of Jazz Fusion group Weather Report . The podcast covers Wayne Shorter's childhood experiences from Newark to NYU and music career from Art Blakey , Miles Davis and Weather Report. It also gives details of Wayne's indirect route into becoming a musician in High School.…

1
Combining Response and Toxicity Data to Implement Project Optimus 23:55

9M ago23:55

23:55

In this JCO Article Insights episode, Subodh Selukar interviews author Dr. Robert Maki on "Combining Response and Toxicity Data to Implement Project Optimus" by Maki, et al published in the Journal of Clinical Oncology September 11, 2024. TRANSCRIPT Subodh Selukar: Welcome to this episode of JCO Article Insights. This is Subodh Selukar, JCO's edito…

Podcaster verdt å lytte til

JCO Podcaster

Podcaster verdt å lytte til

1
JCO Oncology Practice Podcast

American Society of Clinical Oncology (ASCO)

1
Journal of Clinical Oncology (JCO) Podcast

American Society of Clinical Oncology (ASCO)

1
JCOR Parsha & Pizza

1
The Jcoolin’s Podcast

jcoolin

1
Park the Parking: Patient and Caregiver Perspectives on Transportation Barriers in Cancer 31:09

1
JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC 6:54

1
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC 8:42

1
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer 6:52

1
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma 6:24

1
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare 8:17

1
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome 15:50

1
Pregnancy and Breast Cancer 25:53

1
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases 23:59

1
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer 6:47

1
Treatment De-escalation for Favorable Risk Breast Cancer 29:30

1
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment 26:50

1
JCO Article Insights: Smoking Assessment 8:35

1
Prior Authorization: How Did We Get Here and Where Are We Going? 32:05

1
Botensilimab Plus Balstilimab in Advanced Sarcomas 21:00

1
JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer 8:47

1
Optimizing the Electronic Health Record for Patient-Centered Cancer Care 38:55

1
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer 12:12

1
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC 10:21

1
Debt or Dying: The JCO OP Financial Toxicity Special Issue 30:51

1
Air Pollution and Breast Cancer Incidence 25:43

1
JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing 9:01

1
Overcoming Barriers to Make Patient-Partnered Research a Reality 34:38

1
JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma 9:42

1
Quality of Treatment Selection 25:05

1
JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy 9:52

1
Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer 16:40

1
Wayne Shorter A New Perspective 31:38

1
Combining Response and Toxicity Data to Implement Project Optimus 23:55

Hurtigreferanseguide